ICRF has provided more than $72 million to support nearly 2,500 grants to outstanding Israel based cancer researchers. Many of our awardees are responsible for major cancer research breakthroughs.

Recipient(s)InstitutionGrant TypeResearch TopicsGrant Status
Lior Nissim, PhD Hebrew University of Jerusalem ICRF-Cancer Research Institute Immunotherapy Promise Grant Clinical and Translational Research, Immunology and Immunotherapy, Lung Cancer, Synthetic Gene Circuits Active
Ruth Perets, MD, PhD Rambam Health Care Campus Len & Susan Mark Initiative For Ovarian And Uterine/MMMT Cancers Grant Experimental Therapeutics, Ovarian and Uterine Cancer Active
Yitzhak Pilpel, PhD Weizmann Institute of Science Acceleration Grant Computational Biology, Genetics and Genomics, Proteomics and Protein Structures Active
Avi Priel, PhD Hebrew University of Jerusalem Brause Family Initiative for Quality of Life Grant Cancer Pain, Clinical and Translational Research, Drug Mechanisms and Development, Inflammation and Cancer, Pain Management, Quality of Life Active
Gad Rennert, MD, PhD Carmel Medical Center ICRF-City of Hope Jacki and Bruce Barron Cancer Research Scholars’ Program Grant Breast Cancer Active
Asya Rolls, PhD Technion, Israel Institute of Technology ICRF-Cancer Research Institute Immunotherapy Promise Grant Animal Modes of Cancer, Cancer Metastasis, Immunology and Immunotherapy, Inflammation and Cancer, Model Organisms Active
Rotem Rubinstein, PhD Tel Aviv University Research Career Development Award Blood Cancers, Brain Tumors, Gastrointestinal Cancers, Lung Cancer, Oral Cancers, Skin Cancers, Cancer Metastasis, Immunology and Immunotherapy, Oral Cancer, Proteomics and Protein Structures Active
Maayan Salton, PhD Hebrew University of Jerusalem Research Career Development Award Experimental Therapeutics, Melanoma, RNA Metabolism, Skin Cancer Active
Ronit Satchi-Fainaro, PhD Tel Aviv University Research Professorship Grant Brain Cancer, Breast Cancer, Cancer Metastasis, Immunology and Immunotherapy, Lung Cancer, Nanotechnology Active
Thomas Schultheiss, MD, PhD Technion, Israel Institute of Technology Project Grant Cell Signaling, Intracellular Trafficking, Membrane Biology, Model Organisms, Oncogenesis Active